Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
US Department of Justice
Dow
Moodys
Fuji
Medtronic
QuintilesIMS
Cipla
Johnson and Johnson

Generated: January 17, 2018

DrugPatentWatch Database Preview

Pharmacia And Upjohn Company Profile

« Back to Dashboard

Summary for Pharmacia And Upjohn
International Patents:211
US Patents:9
Tradenames:110
Ingredients:85
NDAs:136
Drug Master File Entries: 41

Drugs and US Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn CORTEF ACETATE hydrocortisone acetate OINTMENT;TOPICAL 008917-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 050629-001 Dec 23, 1987 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CAVERJECT alprostadil INJECTABLE;INJECTION 020379-003 Jun 27, 1996 RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn OGEN 2.5 estropipate TABLET;ORAL 083220-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CARDRASE ethoxzolamide TABLET;ORAL 011047-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CAVERJECT IMPULSE alprostadil INJECTABLE;INJECTION 021212-001 Jun 11, 2002 RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn PROTAMINE SULFATE protamine sulfate INJECTABLE;INJECTION 007413-002 Aug 2, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn DOXORUBICIN HYDROCHLORIDE doxorubicin hydrochloride INJECTABLE;INJECTION 050467-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn XANAX XR alprazolam TABLET, EXTENDED RELEASE;ORAL 021434-002 Jan 17, 2003 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn CLEOCIN clindamycin phosphate SWAB;TOPICAL 050537-002 Feb 22, 1994 AT RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Pharmacia And Upjohn

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-004 Sep 24, 1993 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn XANAX alprazolam TABLET;ORAL 018276-002 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn ZYVOX linezolid TABLET;ORAL 021130-002 Apr 18, 2000 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn XALATAN latanoprost SOLUTION/DROPS;OPHTHALMIC 020597-001 Jun 5, 1996 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn PSORCON diflorasone diacetate OINTMENT;TOPICAL 019260-001 Aug 28, 1985 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-008 Jan 27, 1998 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GENOTROPIN PRESERVATIVE FREE somatropin recombinant INJECTABLE;INJECTION 020280-004 Aug 24, 1995 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn DETROL tolterodine tartrate TABLET;ORAL 020771-001 Mar 25, 1998 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn XANAX alprazolam TABLET;ORAL 018276-004 Nov 27, 1985 ➤ Subscribe ➤ Subscribe
Pharmacia And Upjohn GLYNASE glyburide TABLET;ORAL 020051-001 Mar 4, 1992 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for PHARMACIA AND UPJOHN drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Injection 2 mg/mL, 100 mL bag ➤ Subscribe 12/29/2009
➤ Subscribe Injection 2 mg/mL, 300 mL bag ➤ Subscribe 9/1/2009
➤ Subscribe Oral Suspension 100 mg/5 mL ➤ Subscribe 8/3/2009
➤ Subscribe Extended-release Capsules 2 mg and 4 mg ➤ Subscribe 7/30/2007
➤ Subscribe Tablets 600 mg ➤ Subscribe 12/21/2005
➤ Subscribe Tablets 1 g ➤ Subscribe 8/23/2005

Non-Orange Book US Patents for Pharmacia And Upjohn

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,780,279 Method of selection of proteolytic cleavage sites by directed evolution and phagemid display ➤ Subscribe
5,955,346 Variants of human prolactin and human placeatal lactogen ➤ Subscribe
6,428,954 Method for identifying active domains and amino acid residues in polypeptides and hormone variants ➤ Subscribe
5,534,617 Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 ➤ Subscribe
8,637,646 Growth hormone variants ➤ Subscribe
6,451,561 Growth hormone variants ➤ Subscribe
5,834,598 Human growth hormone variants ➤ Subscribe
6,040,136 Enrichment method for variant proteins with altered binding properties ➤ Subscribe
6,022,711 Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1 ➤ Subscribe
6,004,931 Method for inhibiting growth hormone action ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Pharmacia And Upjohn Drugs

Supplementary Protection Certificates for Pharmacia And Upjohn Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB97/003 United Kingdom ➤ Subscribe PRODUCT NAME: IBUTILIDE, OR A PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF, ESPECIALLY IBUTILIDE FUMARATE; REGISTERED: UK 00032/0212 19960930
80020 Netherlands ➤ Subscribe PRODUCT NAME: TOLTERODINE, DESGEWENST IN DE VORM VAN EEN ZOUT MET EEN FYSIOLO GISCH ACCEPTABEL ZUUR, IN HET BIJZONDER TOLTERODINE L-TARTRAAT; NAT. REGISTRATION NO/DATE: RVG 22148, RVG 22149 19980217; FIRST REGISTRATION: SE 13475, 13476 19970905
C0111 Belgium ➤ Subscribe PRODUCT NAME: LATANOPROSTUM; NAT. REGISTRATION NO/DATE: 277 IS 271 F 13 19970617; FIRST REGISTRATION: SE 12716 1996071
/2002 Austria ➤ Subscribe PRODUCT NAME: LINEZOLID; NAT. REGISTRATION NO/DATE: 1-24227 - 1-24230 20011009; FIRST REGISTRATION: GB PL 00032/0259 - PL 00032/0262 20010105
0814 Netherlands ➤ Subscribe PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
0210 Netherlands ➤ Subscribe 300210, 20160920, EXPIRES: 20171112
401 Luxembourg ➤ Subscribe PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE
2004004,C0717738 Lithuania ➤ Subscribe PRODUCT NAME: LINEZOLIDUM ((S)-N-((3-(3-FLUOR-4-(4-MORFOLINIL)FENIL)-2-OKSO--5-OKSAZOLIDINIL)METIL)-ACETAMIDAS); REGISTRATION NO/DATE: 02/8199/2 20030313
C0018 France ➤ Subscribe PRODUCT NAME: ESTRADIOL VALERATE; DIENOGEST; NAT. REGISTRATION NO/DATE: NL35170 20081210; FIRST REGISTRATION: BE327792 20081103
2015000093 Germany ➤ Subscribe PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Queensland Health
Deloitte
Mallinckrodt
QuintilesIMS
Cipla
Express Scripts
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot